Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) EBT Margin (2022 - 2025)

Envoy Medical's EBT Margin history spans 4 years, with the latest figure at 14711.9% for Q3 2025.

  • For Q3 2025, EBT Margin fell 535833.0% year-over-year to 14711.9%; the TTM value through Sep 2025 reached 10773.08%, down 132473.0%, while the annual FY2024 figure was 8920.89%, 310728.0% down from the prior year.
  • EBT Margin for Q3 2025 was 14711.9% at Envoy Medical, down from 7300.0% in the prior quarter.
  • Across five years, EBT Margin topped out at 10919.84% in Q3 2022 and bottomed at 14711.9% in Q3 2025.
  • The 4-year median for EBT Margin is 7341.18% (2024), against an average of 6257.21%.
  • The largest annual shift saw EBT Margin plummeted -1515109bps in 2023 before it surged 4118bps in 2025.
  • A 4-year view of EBT Margin shows it stood at 5746.48% in 2022, then crashed by -104bps to 11701.48% in 2023, then decreased by 0bps to 11745.24% in 2024, then decreased by -25bps to 14711.9% in 2025.
  • Per Business Quant, the three most recent readings for COCH's EBT Margin are 14711.9% (Q3 2025), 7300.0% (Q2 2025), and 12178.26% (Q1 2025).